Inflammation in the CNS and in Alzheimer’s Disease

  • V. H. Perry
  • M. D. Bell
  • D. Anthony
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 17)


The cellular response to neuronal injury or neuronal degeneration in the central nervous system (CNS) is commonly referred to as gliosis. Tradi-tionally, this term was used to refer to the response by astroglia but in more recent years has come to refer to the whole spectrum of cellular reactions to neuronal damage. Since the glia, astroglia, oligodendroglia and microglia are the non-neuronal constituents of the CNS, the term gliosis suggests that this response is wholly intrinsic to the CNS com-partment without a contribution from blood-derived leucocytes. In other tissues cellular degeneration is accompanied by an acute innate inflam-matory response and leucocyte recruitment from the blood but in the CNS the term inflammation appears to have been widely used only in conditions where there is also an overt leucocyte infiltrate such as that seen in multiple sclerosis or viral infections of the CNS. Is it really the case that there is no inflammatory response when neurones degenerate? Is neuronal degeneration accompanied by a more subtle form of inflammation than that seen in other tissues?


Acute Phase Protein Mononuclear Phagocyte Wallerian Degeneration Acute Inflammatory Response Dystrophic Neurites 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham CR (1992) The role of the acute-phase protein a-1 antichymotrypsin in brain dysfunction and injury. Res Immunol 143: 631–636PubMedCrossRefGoogle Scholar
  2. Abraham CR, Selkoe DJ, Potter H (1988) Immunohistochemical identification of the serine protease inhibitor alpha-1 antichymotrypsin in the brain amy-loid deposits of Alzheimer’s disease. Cell 52: 487–501PubMedCrossRefGoogle Scholar
  3. Akiyama H, Ikeda K, Kondo H, Kato M, McGeer PL (1993) Microglia ex-press the type 2 plasminogen activator inhibitor in the brain of control sub-jects and patients with Alzheimer’s disease. Neurosci Lett 164: 233–235PubMedCrossRefGoogle Scholar
  4. Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL (1994a) Expression of MRP14,27E10, interferon-alpha and leukocyte common antigen by re-active microglia in postmortem human brain tissue. J Neuroimmunol 50: 195–201PubMedCrossRefGoogle Scholar
  5. Akiyama H, Tooyama I, Kondo H, Ikeda K, Kimura H, McGeer EG, McGeer PL (1994b) Early response of brain resident microglia to kainic acid-in-duced hippocampal lesions. Brain Res 635: 257–268PubMedCrossRefGoogle Scholar
  6. Andersson P-B, Perry VH, Gordon S (1991) The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-in-duced neuronal degeneration. JNeurosci 42: 201–214Google Scholar
  7. Andersson, P-B, Pen-y, VH, Gordon S (1992a) The acute inflammatory re-sponse to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48: 169–186PubMedCrossRefGoogle Scholar
  8. Andersson P-B, Perry VH, Gordon S (1992b) Intracerebral injection of proin-flammatory cytokines or leukocyte chemotaxins induces minimal myelo-monocytic cell recruitment to the parenchyma of the central nervous sys-tem. J Exp Med 176: 255–259PubMedCrossRefGoogle Scholar
  9. Bauer J, Ganter U, Strauss S, Stadtmuller G, Frommberger U, Bauer H, Volk B, Berger M (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer’s disease. Res Immunol 143: 650–657PubMedCrossRefGoogle Scholar
  10. Bell MD, Perry VH (1995) Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflmmogen or during acute neuronal degeneration. J Neurocytol 24: 695–710PubMedCrossRefGoogle Scholar
  11. Bell MD, Taub DD, Perry VH (1996) Overriding the brain’s intrinsic resist-ance to leukocyte recruitment with intraparenchymal injections of recombi-nant chemokines. Neuroscience (in press)Google Scholar
  12. Bignami A, Dahl D, Nguyen BT, Crosby CJ (1981) The fate of axonal debris in Wallerian degeneration of rat optic and sciatic nerves. J Neuropathol Exp Neurol 40: 337–350CrossRefGoogle Scholar
  13. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical de-struction. Eur Neurol 33: 403–408PubMedCrossRefGoogle Scholar
  14. Breitner JCS, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC (1994) Inverse association of anti-inflammatory treatments and Alzheimer’s disease: initial results of a co-twin control study. Neurology 44: 227–232PubMedCrossRefGoogle Scholar
  15. Cacabelos R, Alvarez XA, Franco-Maside A, Fernandez-Novoa L, Caamano J (1994) Serum tumour necrosis factor ( TNF) in Alzheimer’s disease and multi-infarct dementia. Methods Find Exp Clin Pharmacol 16: 29–35Google Scholar
  16. Cannella B, Cross AH, Raine CS (1990) Upregulation and co-expression of adhesion molecules correlate with relapsing autoimmune demyelination in the the central nervuos system. J Exp Med 172: 1521–1524PubMedCrossRefGoogle Scholar
  17. Castano A, Bell MD, Pen-y VH (1996a) Unusual aspects of inflammation in the nervous system: Wallerian degeneration. Neurobiol Aging (in press)Google Scholar
  18. Castano A, Lawson LJ, Fearn S, Perry VH (1996b) Activation and prolifera-tion of murine microglia are insensitive to glucocorticoids in Wallerian de-generation. Eur J Neurosci (in press)Google Scholar
  19. Chopp WM, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR (1994) Posti-schemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25: 869–75PubMedCrossRefGoogle Scholar
  20. Clark RAF (1989) Wound repair. Curr Opin Cell Biol 1: 1000–1008CrossRefGoogle Scholar
  21. Clark RSB, Schiding JK, Kaczorowski SL, Marion DW, Kochanek PM (1994) Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. J Neurotrauma 5: 499 — 506CrossRefGoogle Scholar
  22. Coffey PJ, Perry VH, Rawlins JNP (1990) An investigation into the earlyGoogle Scholar
  23. stages of the inflammatory response following ibotenic acid-induced neuro-nal degeneration. Neuroscience 35:121–132Google Scholar
  24. DeArmond SJ (1993) Alzheimer’s disease and Creutzfeldt-Jakob disease: overlap of pathogenic mechanisms. Curr Opin Neurol 6: 872–881CrossRefGoogle Scholar
  25. Dickson DW, Lee SC, Mattiace LA, Yn SH, Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alz-heimer’s disease. Glia 7: 75–83PubMedCrossRefGoogle Scholar
  26. Eddleston M, Mucke L (1993) Molecular profile of reactive astrocytes — impli-cations for their role in neurologic disease. Neuroscience 54: 15–36PubMedCrossRefGoogle Scholar
  27. Eikelenbloom P, Stam FC (1982) Immunoglobulins and complement factors in senile plaques: an immunohistochemical study. Acta Neuropathol (Berl) 245: 417–420Google Scholar
  28. Eikelenbloom P, Hack CE, Rozemuller JM, Stam FC (1989) Complement acti-vation in amyloid plaques in Alzheimer’s dementia. Virchows Arch [B] Cell Pathol 56: 259–262CrossRefGoogle Scholar
  29. Eikelenboom P, Rozemuller JM, Kraal G, Stam FC, McBride PA, Bruce ME, Fraser H (1991) Cerebral amyloid plaques in Alzheimer’s disease but not scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch [B] 60: 329–331CrossRefGoogle Scholar
  30. Engelhardt B, Conley FK, Butcher EC (1994) Cell-adhesion molecules on vessels during inflammation in the mouse central nervous system. J Neuroimmunol 51: 199–208PubMedCrossRefGoogle Scholar
  31. Fillit H, Ding WH, Buee L, Kalman J, Altsteil L, Lawlor B, Wolf-Klein G (1991) Elevated circulating tumour necrosis factor levels in Alzheimer’s disease. Neurosci Lett 129: 318–320PubMedCrossRefGoogle Scholar
  32. Games D, Adams D, Alessandrini R et al (1995) Alzheimer’s type neuropathology in transgenic mice overexpressing V717F (3-amyloid precursor protein. Nature 373: 523–527PubMedCrossRefGoogle Scholar
  33. Gasque P, Fontaine M, Morgan BP (1995) Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol 154: 4726–4733Google Scholar
  34. Gehrmann J, Matsumoto Y, Kreutzberg GW (1995) Microglia: intrinsic immunoeffector cell of the brain. Brain Res Rev 20: 269–287PubMedCrossRefGoogle Scholar
  35. Giulian D, Robertson C (1990) Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 27: 33–42PubMedCrossRefGoogle Scholar
  36. Giulian D, Chen J, Ingeman JE, George JK, Naponen M (1989) The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 9: 4416–4429PubMedGoogle Scholar
  37. Granger DN, Kubes P (1994) The microcirculation and inflammation: modula- tion of leucocyte-endothelial cell adhesion. J Leukoc Biol 55: 662–675PubMedGoogle Scholar
  38. Griffin WS, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW (1994) Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett 176: 133–136PubMedCrossRefGoogle Scholar
  39. Itagaki S, McGeer PL, Akiyama H (1988) Presence of T-cytotoxic suppressor and leukocyte common antigen positive cells in Alzheimer disease brain tissue. Neurosci Lett 91: 259–264PubMedCrossRefGoogle Scholar
  40. Jobst KA, Smith AD, Szatmari M, Esiri MM, Jaskowski A, Hindley N, McDonald B, Molyneux M (1994) Rapidly progressing atrophy of medial temporal lobe in Alzheimer’s disease. Lancet 343: 829–830PubMedCrossRefGoogle Scholar
  41. Kalaria RN (1992) Serum amyloid P and related molecules associated with the acute-phase response in Alzheimer’s disease. Res Immunol 143: 637–645PubMedCrossRefGoogle Scholar
  42. Kalaria RN, Harik SI (1989) Reduced glucose transporter at the blood—brain barrier in cerebral cortex in Alzheimer disease. J Neurochem 53: 1083–1088PubMedCrossRefGoogle Scholar
  43. Kalaria RN, Hedera P (1995) Differential degeneration of the cerebral microvasculature in Alzheimer’ s disease. Neuroreport 6: 477–480PubMedCrossRefGoogle Scholar
  44. Kaltschmidt C, Kaltschmidt B, Lannes-Viera J, Kreutzberg GW, Wekerle H, Bauerle PA, Gehrmann J (1994) Transcription factor NF-kB is activated during experimental allergic encephalomyelitis. J Neuroimmunol 55: 99–106PubMedCrossRefGoogle Scholar
  45. Keifer R, Kreutzberg GW (1991) Effects of dexamethasone on microglia acti-vation in vivo: selective downregulation of major histocompatibility com-plex class II expression in regenerating facial nucleus. J Neuroimmunol 34: 99–108CrossRefGoogle Scholar
  46. Konig G, Monning U, Czech C, Prior R, Banati R, Schreiter-Gasser U, Bauer J, Masters CL, Beyreuther K (1992) Identification and differential ex-pression of a novel alternative splice isoform of the beta A4 amyloid pre-cursor protein ( APP) mRNA in leucocytes and brain microglial cells. J Biol Chem 267: 10804–10809Google Scholar
  47. Kunkel S, Standiford T, Kasahara K, Streiter R (1991) Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 17:17— 23Google Scholar
  48. Lawson LJ, Perry VH (1995) The unique characterisitics of inflammatory re-sponses in mouse brain are acquired during postnatal development. Eur J Neurosci 7: 1584–1595PubMedCrossRefGoogle Scholar
  49. Lawson LJ, Frost L, Risbridger J, Fearn S, Perry VH (1994) Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve. J Neurocytol 23: 729–744PubMedCrossRefGoogle Scholar
  50. Licastro F, Morini MC, Polazzi E, Davis LJ (1995) Increase serum alpha 1- antichymotrypsin in patients with probable Alzheimer’s disease: an acute phase reactant without the peripheral acute phase response. J Neuroimmu-nol 57: 71–75Google Scholar
  51. Logan A, Frautschy SA, Gonzalez A-M, Sporn MB, Baird A (1992) Enhanced expression of transforming growth factor in the rat brain after a localized cerebral injury. Brain Res 587: 216–225PubMedCrossRefGoogle Scholar
  52. Logan A, Berry M, Gonzalez A-M, Frautschy SA, Sport MB, Baird A (1994) Effects of transforming growth factor on scar production in the injured central nervous system of the rat. Eur J Neurosci 6: 355–363PubMedCrossRefGoogle Scholar
  53. Maimone D, Gregory S, Amason BG, Reder AT (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neu-roimmunol 32: 67–74Google Scholar
  54. Marty S, Dusart I, Peschanski M (1991) Glial changes following an excito-toxic lesion in the CNS-I microglia/macrophages. Neuroscience 45:529— 539Google Scholar
  55. McGeer PL, McGeer EG (1992) Complement proteins and complement inhibi-tors in Alzheimer’s disease. Res Immunol 143: 621–624PubMedCrossRefGoogle Scholar
  56. McGeer PL, Itagaki S, Tago H, McGeer EG (1987) Reactive microglia in pa-tients with senile dementia of the Alzheimer type are positive for the histo-compatibility glycoprotein HLA-DR. Neurosci Lett 79: 195–200PubMedCrossRefGoogle Scholar
  57. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neuro-sci Lett 107: 341–346CrossRefGoogle Scholar
  58. McGeer PL, McGeer EG, Rogers J, Sibley.1 (1992a) Does anti-inflammatory treatment protect against Alzheimer’s disease? In: Khachaturian ZS, Blass JP (eds) Alzheimer’s disease: new treatment strategies. Dekker, New York, pp 165–171Google Scholar
  59. McGeer PL, Harada N, Kimura H, McGeer EG, Schulzer M (1992b) Pre-valence of dementia amongst elderly Japanese with leprosy: apparent effect of chronic drug therapy. Dementia 3: 146–149Google Scholar
  60. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer E (1993) Microglia in degenerative neurological disease. Glia 7: 84–92PubMedCrossRefGoogle Scholar
  61. Miklossy J, van der Loos H (1991) The long distance effects of brain lesions: visualization of myelinated pathways in the human brain using polarizing and fluorescence microscopy. J Neuropathol Exp Neurol 50: 1–15PubMedCrossRefGoogle Scholar
  62. Miller M, Krangel M (1992) Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12: 17–46PubMedGoogle Scholar
  63. Montero-Menei CN, Sindji L, Pouplard-Barthelaix A, Jehan F, Denechaud L, Darcy F (1994) Lipopolysaccharide intracerebral administration induces minimal inflammatory reaction in rat brain. Brain Res 653: 101–11PubMedCrossRefGoogle Scholar
  64. Movat HZ (1985) The inflammatory reaction. Elsevier, AmsterdamGoogle Scholar
  65. Pasternak JM, Abraham CR, Van Dyke B, Potter H, Younkin SG (1989) As-trocytes in Alzheimer’s disease gray matter express al-antichymotrypsin mRNA. Am J Pathol 135: 827–834Google Scholar
  66. Pearson RC, Esiri MM, Hiorns RW, Wilcock GK, Powell TP (1985) Anatomi-cal correlates of the distribution of the pathological changes in the neocor-tex in Alzheimer disease. Proc Natl Acad Sci USA 82: 4531–4534PubMedCrossRefGoogle Scholar
  67. Perlmutter LS, Barron E, Myers M, Saperia D, Chui HC (1995) Localization of amyloid P component in human brain: vascular staining patterns and as-sociation with Alzheimer’s disease lesions. J Comp Neurol 352: 92–105PubMedCrossRefGoogle Scholar
  68. Perry VH (1994) Macrophages and the nervous system. Molecular biology in-telligence unit. Landes, Austin, TexasGoogle Scholar
  69. Perry VH, Gordon S (1991) Macrophages and the nervous system. Int Rev Cytol 125: 203–244PubMedCrossRefGoogle Scholar
  70. Perry VH, Andersson PB, Gordon S (1993a) Macrophages and inflammation in the central nervous system. Trends Neurosci 16: 268–273PubMedCrossRefGoogle Scholar
  71. Perry VH, Matyszak MK, Fearn S (1993b) Altered antigen expression of microglia in the aged rodent CNS. Glia 7: 60–67PubMedCrossRefGoogle Scholar
  72. Raivich G, Moreno-Flores MT, Moller JC, Kreutzberg GW (1994) Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage col-ony-stimulating factor deficiency in the mouse. Eur J Neurosci 6: 1615–1618PubMedCrossRefGoogle Scholar
  73. Ramsey SC, Weiller C, Myers R, Cremer JE, Luthra SK, Lammertsma AA, Frachowiak RS (1992) Monitoring by PET of macrophage accumulation in brain after ischemic stroke. Lancet 339: 1054–1055CrossRefGoogle Scholar
  74. Rappolee DA, Werb Z (1992) Macrophage-derived growth factors. In: Russel WS, Gordon S (eds) Macrophage biology and activation. Springer, Berlin Heidelberg New York, pp 87–140 (Current topics in microbiology and immunology, vol 181 )Google Scholar
  75. Reid KMB, Thiel S (1993) Clq and related molecules in defence. In: Sim E (ed) The natural immune system: humoral factors. IRL Press, Oxford, pp 151–175Google Scholar
  76. Reid DM, Perry VH, Andersson P-B, Gordon S (1993) Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood—brain barrier. Neuroscience 56: 529–533PubMedCrossRefGoogle Scholar
  77. Relton JK, Rothwell NJ (1992) Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29: 243–246PubMedCrossRefGoogle Scholar
  78. Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigen by cells of the human central nervous system: relationship to the pathology of Alzheimer disease. Neurobiol Aging 9: 339–349PubMedCrossRefGoogle Scholar
  79. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberberg I (1992) Complement activation by (3-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 89: 10016–10020PubMedCrossRefGoogle Scholar
  80. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F (1993) Clincial trial of indomethacin in Alzheimer’ s disease. Neurology 43: 1609–1611PubMedCrossRefGoogle Scholar
  81. Rozemuller JM, van der Valk P, Eikelenboom P (1992) Activated microglia and cerebral amyloid deposits in Alzheimer’s disease. Res Immunol 143: 646649.Google Scholar
  82. Sobel RA, Mitchell ME, Fonfren G (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 136: 1309–1316PubMedGoogle Scholar
  83. Steel DM, Whitehead AS (1993) The acute phase response. In: Sim E (ed) The natural immune system: humoral factors. IRL Press, Oxford, pp 1–29Google Scholar
  84. Streit WJ, Graeber MB (1993) Heterogeneity of microglia and perivascular cell populations: insights gained from the facial nucleus paradigm. Glia 7: 68–74PubMedCrossRefGoogle Scholar
  85. Streit WJ, Graeber MB, Kreutzberg GW (1988) Functional plasticity of micro-glia: a review. Glia 1: 301–307PubMedCrossRefGoogle Scholar
  86. Svensson M, Aldskogius H (1992) Evidence for activation of the complement cascade in the hypoglossal nucleus following peripheral nerve injury. J Neuroimmunol 40: 99–109PubMedCrossRefGoogle Scholar
  87. Svensson M, Aldskogius H (1993a) Infusion of cytosine-arabinoside into the cerebrospinal fluid of the rat brain inhibits the microglial cell proliferation after hypoglossal nerve injury. Glia 7: 286–298PubMedCrossRefGoogle Scholar
  88. Svensson M, Aldskogius H (19936) Synaptic density of axotomized hypoglos-sal motorneurons following pharmacological blockade of the microglial cell proliferation. Exp Neurol 120: 123–131Google Scholar
  89. Tooyama I, Kimura H, Akiyama H, McGeer PL (1990) Reactive microglia ex-press class I and class II major histocompatibility complex antigens in Alz-heimer’s disease. Brain Res 523: 273–280PubMedCrossRefGoogle Scholar
  90. Vora AJ, Perry ME, Hobbs C, Dumonde DC, Brown KA (1995) Selective binding of peripheral blood lymphocytes to the walls of cerebral blood vessels in frozen sections of human brain. J Immunol Methods 180:165— 180Google Scholar
  91. Wegiel J, Wisniewski HM (1990) The complex of microglial cells and amy-loid star in three-dimensional reconstruction. Acta Neuropathol (Berl) 81: 116–124CrossRefGoogle Scholar
  92. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365— 376Google Scholar
  93. Weller M, Stevens A, Sommer N, Melms A, Dichgans J, Wietholter H (1991) Comparative analyis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J Neurol Sci 104: 215–221PubMedCrossRefGoogle Scholar
  94. Whaley K, Lemercier C (1993) The complement system. In: Sim E (ed) The natural immune system: humoral factors. IRL Press, Oxford, pp 120–150Google Scholar
  95. Williams AE, Lawson LJ, Perry VH, Fraser H (1994) Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol 20:47— 55Google Scholar
  96. Wolpe S, Davatelis G, Sherry G, Beutler B, Hesse D, Hguyen H, Moldawer L, Nathan C, Lowry S, Cerami A (1988) Macrophages secrete a novel he-parin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 172: 911–919Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • V. H. Perry
  • M. D. Bell
  • D. Anthony

There are no affiliations available

Personalised recommendations